Cargando…

The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease

PURPOSE OF THE REVIEW: Faecal microbiota transplantation (FMT) has emerged as a potent form of therapeutic microbial manipulation. There is much interest in exploring its potential in conditions such as inflammatory bowel disease (IBD) where disturbances in the gastrointestinal microbiota play a cru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haifer, Craig, Leong, Rupert W, Paramsothy, Sudarshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538387/ https://www.ncbi.nlm.nih.gov/pubmed/33035780 http://dx.doi.org/10.1016/j.coph.2020.08.009

Ejemplares similares

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection
por: Haifer, Craig, et al.
Publicado: (2021)

Therapeutic faecal microbiota transplantation: current status and future developments
por: Borody, Thomas J., et al.
Publicado: (2014)

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

The diagnostic yield of pan‐enteric capsule endoscopy in inflammatory bowel disease: A systematic review and meta‐analysis
por: Tamilarasan, Aravind Gokul, et al.
Publicado: (2022)

Epidemiology of inflammatory bowel disease in South America: A systematic review
por: Selvaratnam, Sriharan, et al.
Publicado: (2019)

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)

Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease
por: Patel, Krish, et al.
Publicado: (2018)

Tryptophan Metabolism ‘Hub’ Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease
por: Bustamante, Sonia, et al.
Publicado: (2022)

Review of pregnancy in Crohn’s disease and ulcerative colitis
por: Laube, Robyn, et al.
Publicado: (2021)

The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
por: Stojek, Magdalena, et al.
Publicado: (2021)

Spp24 is associated with endocytic signalling, lipid metabolism, and discrimination of tissue integrity for ‘leaky-gut’ in inflammatory bowel disease
por: Wasinger, Valerie C., et al.
Publicado: (2020)

Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
por: Borody, Thomas J., et al.
Publicado: (2013)

Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Levy, Alexander N., et al.
Publicado: (2019)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Faecal Microbiota Transplantation and Chronic Kidney Disease
por: Bian, Ji, et al.
Publicado: (2022)

Healthcare providers’ perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review
por: Liu, Yanghua, et al.
Publicado: (2021)

Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
por: Eun, Chang Soo
Publicado: (2017)

Defined microbiota transplant restores Th17/RORγt(+) regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
por: Britton, Graham J., et al.
Publicado: (2020)

Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Basson, Abigail R, et al.
Publicado: (2020)

Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
por: Pudipeddi, Aviv, et al.
Publicado: (2022)

Expert-led didactic versus self-directed audiovisual training of confocal laser endomicroscopy in evaluation of mucosal barrier defects
por: Huynh, Roy, et al.
Publicado: (2018)

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
por: Tan, Pufang, et al.
Publicado: (2020)

Faecal microbiota transplantation simultaneously ameliorated patient's essential tremor and irritable bowel syndrome
por: Liu, Xu‐juan, et al.
Publicado: (2020)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021)

The Role of the Microbiota in Feline Inflammatory Bowel Disease
por: Simpson, Kenneth W.
Publicado: (2016)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Free Faecal Water: Analysis of Horse Faecal Microbiota and the Impact of Faecal Microbial Transplantation on Symptom Severity
por: Laustsen, Louise, et al.
Publicado: (2021)

Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?
por: Xiang, Liyuan, et al.
Publicado: (2020)

Faecal microbiota transplantation: indications, evidence and safety
por: Soo, Wei Ting, et al.
Publicado: (2020)

Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Zhang, Xiaochen, et al.
Publicado: (2022)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Fecal Microbiota Transplants for Inflammatory Bowel Disease Treatment: Synthetic- and Engineered Communities-Based Microbiota Transplants Are the Future
por: Khan, Raees, et al.
Publicado: (2022)

Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease
por: Wang, Xiaoli, et al.
Publicado: (2022)

Regulation, risk and safety of Faecal Microbiota Transplant
por: Merrick, Blair, et al.
Publicado: (2020)

Faecal microbiota transplantation: a regulatory hurdle?
por: Verbeke, Frederick, et al.
Publicado: (2017)

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
por: D. Goldenberg, Simon, et al.
Publicado: (2021)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
por: Khalil, Ahmed F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v6o4scl9o7d3dr91liht370ivi